A: Antigenic drift - Parker Core Knowledge

Understanding the Context

What Is Antigenic Drift?

Antigenic drift is the result of continuous, incremental changes in a virus’s genetic material, driven largely by error-prone RNA replication during viral reproduction. For influenza viruses, which have a single-stranded RNA genome, replication lacks efficient proofreading mechanisms, increasing the likelihood of mutations.

Each mutation may alter one or more amino acids in surface antigens—especially in the HA protein of the influenza A virus. These subtle changes reduce the effectiveness of antibodies generated from previous infections or vaccinations, allowing the virus to infect the same host population despite prior immunity.

Key Insights

Biological Mechanism of Antigenic Drift

The influenza virus genome consists of eight RNA segments encoding various structural proteins. The genes for HA and NA—vital for viral attachment and release—are particularly prone to mutation. Over time, incremental substitutions accumulate in the gene sequences, altering the protein structure slightly but significantly.

Because immune recognition is highly specific to protein structure, even minor changes can diminish antibody binding. This immune evasion allows the virus to spread rapidly during seasonal outbreaks.

Antigenic Drift vs. Antigenic Shift

Final Thoughts

While antigenic drift involves gradual mutation, a related but distinct process—antigenic shift—occurs through reassortment of entire gene segments when two or more influenza strains infect the same host cell. Antigenic shift can lead to pandemic strains with novel surface proteins, whereas antigenic drift drives annual seasonal epidemics.

Understanding the difference is crucial for surveillance strategies and vaccine forecasting.

Public Health Impact and Vaccine Implications

Antigenic drift presents a continual challenge for global health systems. Annual strain changes necessitate periodic updates to seasonal influenza vaccines to maintain protective efficacy. Public health organizations like the WHO monitor circulating strains closely to predict dominant variants and update vaccine compositions accordingly.

Failure to account for drift can result in vaccine mismatch, reducing effectiveness and increasing flu morbidity and mortality—especially in vulnerable populations like the elderly and immunocompromised.